Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (26.46 KB, 5 trang )
Chapter 089. Pancreatic Cancer
(Part 5)
Figure 89-2
Survival by adjuvant chemotherapy. Kaplan-
Meier estimates of survival
from the European Study Group for Panc
reatic Cancer 1 (ESPAC1) trial for the
comparison of adjuvant chemotherapy versus no adjuvant chemotherapy (CT) in
patients with resected pancreatic cancer (hazard ratio for death, 0.71; 95%
confidence interval, 0.55 to 0.92; p = .009). (Reprinted with per
mission from JP
Neoptolemos, DD Stocken, H Friess, et al: A randomized trial of
chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N
Engl J Med 350:1200–
1210, 2004. Copyright 2004, Massachusetts Medical
Society.)
Further Readings
Alexakis N et al: Current standards of surgery for pancreatic cancer. Br J
Surg 91:1410, 2004 [PMID: 15499648]
Barugola G et al: The determinant factors of recurrence following resection
for ductal pancreatic cancer. JOP 8(Suppl 1):132, 2007
Chua YJ,
Cunningham D: Chemotherapy for advanced pancreatic cancer.
Best Pract Res Clin Gastroenterol 20:327, 2006 [PMID: 16549331]